α2-macroglobulin associates with β-amyloid peptide and prevents fibril formation

被引:186
作者
Hughes, SR
Khorkova, O
Goyal, S
Knaeblein, J
Heroux, J
Riedel, NG
Sahasrabudhe, S
机构
[1] Hoechst Marion Roussel Inc, Biotechnol Grp, Bridgewater, NJ 08876 USA
[2] Hoechst Marion Roussel Inc, Cent Nervous Syst Dis Grp, Bridgewater, NJ 08876 USA
关键词
D O I
10.1073/pnas.95.6.3275
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We have used the yeast two-hybrid system to isolate cDNAs encoding proteins that specifically interact with the 42-aa beta-amyloid peptide (A beta), a major constituent of senile plaques in Alzheimer's disease, The carboxy terminus of alpha(2)-macroglobulin (alpha 2M), a proteinase inhibitor released in response to inflammatory stimuli, was identified as a strong and specific interactor of A beta, utilizing this system, Direct evidence for this interaction was obtained by co-immunoprecipitation of alpha 2M with A beta from the yeast cell, and by formation of SDS-resistant A beta complexes in polyacrylamide gels by using synthetic A beta and purified alpha 2M, The association of A beta with alpha 2M and various purified amyloid binding proteins was assessed by employing a method measuring protein-protein interactions in liquid phase, The dissociation constant by this technique for the alpha 2M-A beta association using labeled purified proteins was measured (K-d = 350 nM), Electron microscopy showed that a 1:8 ratio of alpha 2M to A beta prevented fibril formation in solution; the same ratio to A beta of another acute phase protein, alpha(1)-antichymotrypsin, was not active in preventing fibril formation in vitro, These results were corroborated by data obtained from an in vitro aggregation assay employing Thioflavine T, The interaction of alpha 2M with A beta suggests new pathway(s) for the clearance of the soluble amyloid peptide.
引用
收藏
页码:3275 / 3280
页数:6
相关论文
共 39 条
[1]   alpha 1-antichymotrypsin interaction with A beta(1-42) does not inhibit fibril formation but attenuates the peptide toxicity [J].
Aksenov, MY ;
Aksenova, MV ;
Carney, JM ;
Butterfield, DA .
NEUROSCIENCE LETTERS, 1996, 217 (2-3) :117-120
[2]  
[Anonymous], 1988, Antibodies: A Laboratory Manual
[3]  
Ausubel FM., 1994, Curr. Protoc. Mol. Biol
[4]   Characterization of new polyclonal antibodies specific for 40 and 42 amino acid long amyloid beta peptides: Their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases [J].
Barelli, HL ;
Lebeau, A ;
Vizzavona, J ;
Delaere, P ;
Chevallier, N ;
Drouot, C ;
Marambaud, P ;
Ancolio, K ;
Buxbaum, JD ;
Khorkova, O ;
Heroux, J ;
Sahasrabudhe, S ;
Martinez, J ;
Warter, JM ;
Mohr, M ;
Checler, F .
MOLECULAR MEDICINE, 1997, 3 (10) :695-707
[5]   ALPHA(2)-MACROGLOBULIN, A MULTIFUNCTIONAL BINDING-PROTEIN WITH TARGETING CHARACTERISTICS [J].
BORTH, W .
FASEB JOURNAL, 1992, 6 (15) :3345-3353
[6]   A BACTERIAL REPRESSOR PROTEIN OR A YEAST TRANSCRIPTIONAL TERMINATOR CAN BLOCK UPSTREAM ACTIVATION OF A YEAST GENE [J].
BRENT, R ;
PTASHNE, M .
NATURE, 1984, 312 (5995) :612-615
[7]   A EUKARYOTIC TRANSCRIPTIONAL ACTIVATOR BEARING THE DNA SPECIFICITY OF A PROKARYOTIC REPRESSOR [J].
BRENT, R ;
PTASHNE, M .
CELL, 1985, 43 (03) :729-736
[8]   GENERATION OF BETA-AMYLOID IN THE SECRETORY PATHWAY IN NEURONAL AND NONNEURONAL CELLS [J].
BUSCIGLIO, J ;
GABUZDA, DH ;
MATSUDAIRA, P ;
YANKNER, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (05) :2092-2096
[9]  
CHU CT, 1994, LAB INVEST, V71, P792
[10]   A KINETIC-MODEL FOR AMYLOID FORMATION IN THE PRION DISEASES - IMPORTANCE OF SEEDING [J].
COME, JH ;
FRASER, PE ;
LANSBURY, PT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) :5959-5963